Submitted by f@nt@il on
The ABC&D's of Reimbursment: Medicare Part A

Carolyn Liptak, MBA, RPh, brings more than 30 years of experience in the healthcare industry and currently serves as the Pharmacy Executive Director for Regulatory, Compliance & Financial Performance on the Vizient Center for Pharmacy Practice Excellence team. She has provided directorial leadership for inpatient, outpatient, retail and specialty pharmacy operations and clinical strategy. Her areas of expertise include regulatory compliance, revenue integrity, sterile compounding, and controlled substance diversion surveillance. She currently is a member of the Pharmacy Advisory Council at The Joint Commission.

Prior to joining Vizient, Carolyn served in leadership roles at Texas Children’s Hospital and Memorial Hermann Health System in Houston as well as The Medical Center of Aurora and the University of Colorado Hemophilia & Thrombosis Center in Denver. Carolyn received a Bachelor of Science degree from the University of Louisiana at Monroe School of Pharmacy and a master’s degree in Business Administration from the University of Houston Clear Lake. She is based remotely in Denver, Colorado.

LEARNING OBJECTIVES:

• To discuss reimbursement from Centers for Medicare and Medicaid Services for new medications
• Identify ways to stay informed of new and changing NTAP drug payments that exist
• Recall the purpose of NTAP drug payments in the Inpatient Prospective Payment System (IPPS) and the
requirements for eligibility

Latest Videos
View all Videos
Executive Insights
Feb 25, 2025
Hinnah Farooqi serves as the Director of Pharmacy at New York Presbyterian in Queens, a diverse hospital with 500 beds. She discusses the hospital's efforts to improve efficiency and patient safety by using more automation, like RFID technology called Intelligard. Hinnah also emphasizes teamwork with the central sterile team and the hospital's focus on developing leaders and improving management skills through partnerships and internal programs.
Feb 25, 2025

Valerie Hoffman is the Associate Marketing Director at Long Grove Pharmaceuticals. Valerie prioritizes drug safety and aims to enhance it through clear, distinctive labeling. She also emphasizes open communication in leadership and works to build strong customer relationships. 

Executive Insights
Feb 10, 2025

Mark Saxon, the CEO of Safecor Health, discusses the company's strategic plans for 2025, emphasizing their commitment to unit dose drug repackaging and error-free medication delivery. Mark highlights the importance of cultural change and core values such as care, commitment, and excellence in leadership. He expresses excitement about tackling healthcare challenges, cherishes family traditions, and is looking forward to a successful 2025.